Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carolina Barnett

Showing results (1-10 of 131) with videos related to

Pageof 14
Sort By:
International Review of Neurobiology|October 16, 2025
Myasthenia gravis in womenLaura O'Connor, Carolina Barnett-Tapia
Expert Opinion on Pharmacotherapy|November 1, 2019
Current pharmacotherapeutic options for myasthenia gravisCarolina Barnett, Raha Tabasinejad, Vera Bril
Frontiers in Neurology|July 28, 2020
Novel Treatments in Myasthenia GravisDeepak Menon, Carolina Barnett, Vera Bril
International Review of Neurobiology|October 16, 2025
Future perspectives on myasthenia gravis and related disordersCarolina Barnett Tapia, Anna Rostedt Punga
Muscle & Nerve|April 12, 2014
INCAT disability score: a critical analysis of its measurement propertiesAri Breiner, Carolina Barnett, Vera Bril
Muscle & Nerve|April 14, 2012
Predictors of response to immunomodulation in patients with myasthenia gravisHans D Katzberg, Carolina Barnett, Vera Bril
Frontiers in Neurology|July 3, 2023
Time to achieve a patient acceptable symptom state in myasthenia gravisRodrigo Martinez-Harms, Carolina Barnett, Vera Bril
The Primary Care Companion for CNS Disorders|October 27, 2022
Like a Game of Chess, Every Move Matters: The Role of Antibodies in the Myasthenia Gravis Treatment LandscapeVera Bril, Nicholas J Silvestri, Carolina Barnett-Tapia
Neuromuscular Disorders : NMD|March 12, 2013
Performance of individual items of the quantitative myasthenia gravis scoreT Carolina Barnett, Vera Bril, Aileen M Davis
The Primary Care Companion for CNS Disorders|May 27, 2022
A Review of Disease Mechanisms and Current and Emerging Treatment Options for Generalized Myasthenia GravisVera Bril, Nicholas J Silvestri, Carolina Barnett-Tapia
Pageof 14

Showing results (1-10 of 131) with videos related to

Sort By:
Pageof 14
International Review of Neurobiology|October 16, 2025
Myasthenia gravis in womenLaura O'Connor, Carolina Barnett-Tapia
Expert Opinion on Pharmacotherapy|November 1, 2019
Current pharmacotherapeutic options for myasthenia gravisCarolina Barnett, Raha Tabasinejad, Vera Bril
Frontiers in Neurology|July 28, 2020
Novel Treatments in Myasthenia GravisDeepak Menon, Carolina Barnett, Vera Bril
International Review of Neurobiology|October 16, 2025
Future perspectives on myasthenia gravis and related disordersCarolina Barnett Tapia, Anna Rostedt Punga
Muscle & Nerve|April 12, 2014
INCAT disability score: a critical analysis of its measurement propertiesAri Breiner, Carolina Barnett, Vera Bril
Muscle & Nerve|April 14, 2012
Predictors of response to immunomodulation in patients with myasthenia gravisHans D Katzberg, Carolina Barnett, Vera Bril
Frontiers in Neurology|July 3, 2023
Time to achieve a patient acceptable symptom state in myasthenia gravisRodrigo Martinez-Harms, Carolina Barnett, Vera Bril
The Primary Care Companion for CNS Disorders|October 27, 2022
Like a Game of Chess, Every Move Matters: The Role of Antibodies in the Myasthenia Gravis Treatment LandscapeVera Bril, Nicholas J Silvestri, Carolina Barnett-Tapia
Neuromuscular Disorders : NMD|March 12, 2013
Performance of individual items of the quantitative myasthenia gravis scoreT Carolina Barnett, Vera Bril, Aileen M Davis
The Primary Care Companion for CNS Disorders|May 27, 2022
A Review of Disease Mechanisms and Current and Emerging Treatment Options for Generalized Myasthenia GravisVera Bril, Nicholas J Silvestri, Carolina Barnett-Tapia
Pageof 14